It’s always a good day when a new treatment, especially one for lung cancer, becomes available. It’s even better when the drug trial was stopped early because the results were so clear. Now, Tagrisso is the first adjuvant treatment approved for non-small cell lung cancer.Original Article
You may also like
1bn Persons Affected with Presbyopia Worldwide—Eye...
Isaac Ladipo Oluwole: Nigeria’s Father of Public...
Egbujiobi to Institute Annual Grants for Pharmacy...
Experts Educate Mushin Residents on Heart Health
20 Skills most Successful Entrepreneurs have Developed
Group to Reduce Maternal Mortality by 5% in Dec 2023
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.